FDA.reportPublic FDA data

Pegasys 180 MCG in 1 ML Injection

RxCUI
352297
RxNorm name
Pegasys 180 MCG in 1 ML Injection
Display name
Pegasys 180 MCG in 1 ML Injection
Full name
Pegasys 180 MCG in 1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103964Pegasyspeginterferon alfa-2a351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d9290e5b-6d40-2318-e053-2995a90a9916Pegasys 180 MCG in 1 ML Injection [PSN] · 1 ML peginterferon alfa-2a 0.18 MG/ML Injection [Pegasys] [SBD] · 1 ML Pegasys 0.18 MG/ML Injection [SY] · Pegasys 0.18 MG/ML Injectable Solution [SY] · Pegasys 180 MCG/ML Injectable Solution [SY]544These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 200220250811